Literature DB >> 11009071

Comorbidity of mild cognitive disorder and depression--a neuropsychological analysis.

F M Reischies1, P Neu.   

Abstract

Mild cognitive impairment is found in many cases of depression, and it is mostly assumed to improve during the time course of depression remission. Recent data question the reversibility of low cognitive test performance in depression. The aim of this study is to determine the degree of reversibility and the proportion of patients who will not demonstrate reversibility of cognitive dysfunction. Consecutive inpatients suffering from depression (N=102) were investigated and N=82 matched control subjects. N=57 of the patients were diagnosed as major depression according to DSM-IV. A total of N=67 could be retested after remission of depression (N=32 of the patients with major depression) and a matched control group (N=62). Neuropsychological tests were applied in a test session which avoids the effects of fatigue in the patients by the short duration of strenuous tests. For most neuropsychological tests an impaired performance in the depressed patients was found. About one third of the depression subjects performed at an impaired level in tests of averbal memory and verbal fluency (below 5th percentile). In the follow-up investigation, a slight improvement in performance could be assessed for both the depression and the control group, which was, however, attributed to a general test training effect. No normalization of cognitive test performance was found in spite of complete recovery of the affective symptoms. No correlation between the duration of the disease before the index episode or number of episodes and cognitive deficits could be found. The data of the neuropsychological deficits of depressed patients, which are stable in the time course of the affective disorder, may indicate that these patients may suffer from comorbidity of both depression and mild cognitive disorder. The findings are discussed as 1) indicating only a minor impact of the depressed mood on the cognitive performance and 2) they are consistent with a role of brain lesions which have been reported in several studies in a subgroup of depression.

Entities:  

Mesh:

Year:  2000        PMID: 11009071     DOI: 10.1007/s004060070023

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  25 in total

1.  Parsing trait and state effects of depression severity on neurocognition: Evidence from a 26-year longitudinal study.

Authors:  Casey Sarapas; Stewart A Shankman; Martin Harrow; Joseph F Goldberg
Journal:  J Abnorm Psychol       Date:  2012-05-28

Review 2.  Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.

Authors:  Hannah R Snyder
Journal:  Psychol Bull       Date:  2012-05-28       Impact factor: 17.737

3.  Neuropsychological indicators of preclinical Alzheimer's disease among depressed older adults.

Authors:  Nicole C Rushing; Natalie Sachs-Ericsson; David C Steffens
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2013-05-09

4.  Evaluation of the Effects of Severe Depression on Global Cognitive Function and Memory.

Authors:  Shawn M McClintock; Munro Cullum; Mustafa M Husain; A John Rush; Rebecca G Knapp; Martina Mueller; Georgios Petrides; Shirlene Sampson; Charles H Kellner
Journal:  CNS Spectr       Date:  2010-05       Impact factor: 3.790

5.  [Mild cognitive impairment in old age. Diagnostics and prognostic significance].

Authors:  F M Reischies; F Wertenauer
Journal:  Nervenarzt       Date:  2011-11       Impact factor: 1.214

6.  Executive function improvement upon remission of recurrent unipolar depression.

Authors:  Eva Biringer; Astri Lundervold; Kirsten Stordal; Arnstein Mykletun; Jens Egeland; Ronald Bottlender; Anders Lund
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-04-01       Impact factor: 5.270

Review 7.  Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia.

Authors:  Howard Chertkow; Fadi Massoud; Ziad Nasreddine; Sylvie Belleville; Yves Joanette; Christian Bocti; Valérie Drolet; John Kirk; Morris Freedman; Howard Bergman
Journal:  CMAJ       Date:  2008-05-06       Impact factor: 8.262

8.  Hippocampal expression of aryl hydrocarbon receptor nuclear translocator 2 and neuronal PAS domain protein 4 in a rat model of depression.

Authors:  Zhaohui Zhang; Pengge Fei; Junlin Mu; Wenqiang Li; Jinggui Song
Journal:  Neurol Sci       Date:  2013-07-17       Impact factor: 3.307

9.  Course of illness, hippocampal function, and hippocampal volume in major depression.

Authors:  Glenda M MacQueen; Stephanie Campbell; Bruce S McEwen; Kathryn Macdonald; Shigeko Amano; Russell T Joffe; Claude Nahmias; L Trevor Young
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-24       Impact factor: 11.205

10.  Cognitive functioning in major depression--a summary.

Authors:  Asa Hammar; Guro Ardal
Journal:  Front Hum Neurosci       Date:  2009-09-25       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.